Krylov Igor Konstantinovich

Krylov Igor Konstantinovich

As of October, 2017, Igor Krylov is the managing director of Marathon Pharma.

Biography

Igor Konstantinovich Krylov was born on July 31, 1964.

Education

In 1987 graduated from "Military-medical academy Decorated with the Order of the Red Banner of the Order of Lenin of S.M. Kirov" in "Medical case", received qualification of the doctor.

Career

Till 1994 served in Armed forces of the USSR and the Russian Federation. Having come to civil service, began to work as the endocrine medicines manager in representative office of the international pharmaceutical company Elly Lilly.

Since 1999 Igor Krylov became the manager of the federal project in this company, was engaged in marketing strategy development of endocrine medicines, directed group of area managers and medical representatives, participated in key professional actions.

From 2002 to 2003 passed to a similar position into Aventis companies. Implemented the most difficult project on an output to the Russian market of one of the leading medicines (insulin) of this firm.

In 2003 Igor Krylov became the CEO of pharmaceutical company ICN, and in 2004 headed the Pharmstandard holding which is again formed based on this company. Worked in this position till December, 2014.

For 2003-2009 led Pharmstandard company into the lead of the pharmaceutical industry. In 2009 SEO took the 35th place in the rating of the best Russian.

Worked as the director of work with state bodies and strategic development of Astrazenek in the region "Russia and Eurasia".

From October, 2015 to October, 2016 held a position of the senior vice president – the operating officer of Medsi company.

In April, 2017 it is appointed the managing director of Marathon Group investment company. Is engaged in strategic development of pharmaceutical division of Marafon Group holding, based by Alexander Vinokurov.^[1]

Notes